North America Bioabsorbable Stents Market

North America Bioabsorbable Stents Market Size & Growth (2022 to 2027)

The size of the North America Bioabsorbable stents market is advancing to achieve USD 2386.52 million by 2027 from USD 421.16 million in 2022, growing at a CAGR of 41.47% in the course of the forecast period.

The increasing prevalence of the geriatric population suffering from pulmonary and coronary artery diseases is leading to a constant rise in demand for the Bioabsorbable Stents market in North America. The novel bioabsorbable stents are continually emerging into the market owing to the rapid research and technological advancements, which are propelling the growth of the Bioabsorbable stents market in North America. In North America, government authorities are focusing on enhancing healthcare services which are contributing to the growth of this market. The increasing adoption rate of bioabsorbable stents by patients and physicians in North America is also boosting up the growth rate of the Bioabsorbable stents market in this area. The rise in demand for minimally invasive surgery techniques and unhealthy habits of people are contributing to the growth of the market.

Rising prevalence of CAD and PAD, and continuously increasing patient pool in hospitals are supposed to boost the demand for bioabsorbable stents and develop growth opportunities for the stakeholders in the market. Increased research and development activities to produce novel and innovative treatment methods and advanced bioabsorbable stents are presumed to be creating more growth opportunities for the market over the forecast period. Expanding healthcare infrastructure and boosting economies of countries like the U.S, Canada and others in North America are foreseen to create lucrative opportunities for the market players in the region during the forecast period. The continuously rising rate of coronary artery and pulmonary artery diseases and increasing preference of patients for cost-effective, minimally invasive procedures, quality treatment procedures are expected to provide more opportunities for the growth of the Bioabsorbable stents market in North America. 

Complications associated with bioabsorbable stents are posing a significant challenge for the key players in the regional market and is expected to restrain the growth rate of the market during the forecast period. Availability o traditional stents with lesser costs are also limiting the growth of North America bioabsorbable stents market. 

This research report on the North American bioabsorbable Stents Market has been segmented and sub-segmented into the following categories.

By Material: 

• Polymer Stents
• Metallic Stents

By Absorption Rate:

• Slow Absorption Rate Stents
• High Absorption Rate Stents

By Application: 

• Coronary Artery Disease
• Peripheral Artery Disease

By End User: 

• Hospitals
• Cardiac Centers

By Country: 

• United States,
• Canada
• Rest Of North America

Regionally, Canada is leading the North America bioabsorbable stents market and is anticipated to contribute a significant share of revenues during the forecast period owing to the factors like increasing demand for bioabsorbable stents due to benefits associated with them, the influx of novel and innovative products in the region, and growing adoption rate of non-invasive techniques by patients.

Some of the major players in North America bioabsorbable stents market are Elixir Medical Corporation, Arterius Limited, Amaranth Medical Inc, Abbott Laboratories, Arterial Remodeling Technologies S.A, Biotronik, Kyoto Medical Planning Co Ltd., Reva Medical Inc, Tepha.Inc, SMT and Xenogenics Corporation.